226 related articles for article (PubMed ID: 11874692)
21. Distinct mechanisms of action of selective estrogen receptor modulators in breast and osteoblastic cells.
Nuttall ME; Stroup GB; Fisher PW; Nadeau DP; Gowen M; Suva LJ
Am J Physiol Cell Physiol; 2000 Nov; 279(5):C1550-7. PubMed ID: 11029302
[TBL] [Abstract][Full Text] [Related]
22. Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs.
Tapia-Gonzalez S; Carrero P; Pernia O; Garcia-Segura LM; Diz-Chaves Y
J Endocrinol; 2008 Jul; 198(1):219-30. PubMed ID: 18460549
[TBL] [Abstract][Full Text] [Related]
23. Skeletal effects of selective oestrogen receptor modulators (SERMs).
Díez JL
Hum Reprod Update; 2000; 6(3):255-8. PubMed ID: 10874570
[TBL] [Abstract][Full Text] [Related]
24. Modern antioestrogens and the coming revolution in women's health care.
Evans A; Vollenhoven B; Healy D
Aust N Z J Obstet Gynaecol; 1999 Aug; 39(3):334-40. PubMed ID: 10554946
[TBL] [Abstract][Full Text] [Related]
25. Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.
Cerrato F; Fernández-Suárez ME; Alonso R; Alonso M; Vázquez C; Pastor O; Mata P; Lasunción MA; Gómez-Coronado D
Br J Pharmacol; 2015 Mar; 172(5):1379-94. PubMed ID: 25395200
[TBL] [Abstract][Full Text] [Related]
26. Expressions of vascular endothelial growth factor and nitric oxide synthase III in the thyroid gland of ovariectomized rats are upregulated by estrogen and selective estrogen receptor modulators.
de Araujo LF; Grozovsky R; dos Santos Pereira MJ; de Carvalho JJ; Vaisman M; Carvalho DP
Thyroid; 2010 Jan; 20(1):85-92. PubMed ID: 20017619
[TBL] [Abstract][Full Text] [Related]
27. Selective estrogen receptor modulators prevent neointima formation after vascular injury.
Savolainen-Peltonen H; Luoto NM; Kangas L; Häyry P
Mol Cell Endocrinol; 2004 Nov; 227(1-2):9-20. PubMed ID: 15501580
[TBL] [Abstract][Full Text] [Related]
28. Differential SERM effects on corepressor binding dictate ERalpha activity in vivo.
Webb P; Nguyen P; Kushner PJ
J Biol Chem; 2003 Feb; 278(9):6912-20. PubMed ID: 12482846
[TBL] [Abstract][Full Text] [Related]
29. Selective estrogen receptor modulator effects in the rat brain.
Zhou W; Koldzic-Zivanovic N; Clarke CH; de Beun R; Wassermann K; Bury PS; Cunningham KA; Thomas ML
Neuroendocrinology; 2002 Jan; 75(1):24-33. PubMed ID: 11810032
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.
Suuronen T; Nuutinen T; Huuskonen J; Ojala J; Thornell A; Salminen A
Inflamm Res; 2005 May; 54(5):194-203. PubMed ID: 15953991
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterization of a novel oestrogen antagonist, ZK 119010, in rats and mice.
Nishino Y; Schneider MR; Michna H; von Angerer E
J Endocrinol; 1991 Sep; 130(3):409-14. PubMed ID: 1834757
[TBL] [Abstract][Full Text] [Related]
32. Evidence for an estrogen-like action of raloxifene upon the hypothalamic-pituitary unit: raloxifene inhibits luteinizing hormone secretion and stimulates prolactin secretion in ovariectomized female rats.
Pinilla L; Gonzalez LC; Tena-Sempere M; Aguilar E
Neurosci Lett; 2001 Oct; 311(3):149-52. PubMed ID: 11578816
[TBL] [Abstract][Full Text] [Related]
33. Selective oestrogen receptor modulators decrease the inflammatory response of glial cells.
Arevalo MA; Diz-Chaves Y; Santos-Galindo M; Bellini MJ; Garcia-Segura LM
J Neuroendocrinol; 2012 Jan; 24(1):183-90. PubMed ID: 21564348
[TBL] [Abstract][Full Text] [Related]
34. In vitro effects of oestrogens, antioestrogens and SERMs on pancreatic solid pseudopapillary neoplasm-derived primary cell culture.
Tognarini I; Tonelli F; Nesi G; Martineti V; Galli G; Gozzini A; Colli E; Zonefrati R; Paglierani M; Marini F; Sorace S; Cavalli T; Cavalli L; Tanini A; Brandi ML
Cell Oncol; 2010; 32(5-6):331-43. PubMed ID: 20364070
[TBL] [Abstract][Full Text] [Related]
35. Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women.
Ismail SI; Bain C; Hagen S
Cochrane Database Syst Rev; 2010 Sep; (9):CD007063. PubMed ID: 20824855
[TBL] [Abstract][Full Text] [Related]
36. Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism.
Mercier I; Mader S; Calderone A
Cardiovasc Res; 2003 Oct; 59(4):883-92. PubMed ID: 14553828
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Ki-67 antigen expression in the vaginal epithelium of castrated female rats treated with raloxifene and tamoxifen: a comparative study.
de Moura-Leal AC; de Sousa JM; de Moura-Leal H; de Sousa GV; Alencar AP; Borges US; Pinto GR; da Silva BB
Gynecol Endocrinol; 2016 Jun; 32(6):453-6. PubMed ID: 27199299
[TBL] [Abstract][Full Text] [Related]
38. Oestrogenic action of neonatal tamoxifen on the hypothalamus and reproductive system in female mice.
Parandin R; Behnam-Rassouli M; Mahdavi-Shahri N
Reprod Fertil Dev; 2016 Apr; ():. PubMed ID: 27064117
[TBL] [Abstract][Full Text] [Related]
39. Evidence for the involvement of central conversion of testosterone to oestradiol-17 beta in the regulation of luteinizing hormone secretion in the cockerel.
Wilson SC; Knight PG; Cunningham FJ
J Endocrinol; 1983 Nov; 99(2):301-10. PubMed ID: 6655411
[TBL] [Abstract][Full Text] [Related]
40. Neuroendocrine regulation of growth hormone and androgen axes by selective estrogen receptor modulators in healthy men.
Birzniece V; Sata A; Sutanto S; Ho KK
J Clin Endocrinol Metab; 2010 Dec; 95(12):5443-8. PubMed ID: 20843951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
